fridays health tirzepatide Reviews Fridays | GLP-1 Telehealth |

New weight loss medications known as GLP-1 agonists highly effective drugs that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have been shown to reduce symptoms of the common sleep disorder, which causes temporary pauses in breathing during sleep and increases the risk of serious conditions like heart disease and diabetes

Some of these studies are small, meaning they involve only a few people, while others are larger and include many participants

In addition, these drugs appear to slow the movement/digestion of food from the stomach to the small intestine

By engaging two key hormone receptors involved in appetite control and blood sugar stability, the treatment helps signal fullness more effectively and reduces the urge to overeat